Park National Corp Eli Lilly & CO Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Park National Corp holds 11,400 shares of LLY stock, worth $8.99 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

11,400

Previous 11,492 0.8%

Holding current value

$8.99 Million

Previous $10.4 Million 2.93%

% of portfolio

0.36%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$772.14 - $960.02 $71,036 - $88,321	-92 Reduced 0.8%	11,400 $10.1 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $187,741 - $235,441	-259 Reduced 2.2%	11,492 $10.4 Million
Q1 2024 Apr 01, 2024	SELL	$592.2 - $792.28 $281,295 - $376,333	-475 Reduced 3.89%	11,751 $9.14 Million
Q4 2023 Jan 02, 2024	SELL	$525.19 - $619.13 $267,846 - $315,756	-510 Reduced 4.0%	12,226 $7.13 Million
Q3 2023 Oct 02, 2023	SELL	$434.7 - $599.3 $26,082 - $35,958	-60 Reduced 0.47%	12,736 $6.84 Million
Q2 2023 Jul 03, 2023	SELL	$350.74 - $468.98 $712,703 - $952,967	-2,032 Reduced 13.7%	12,796 $6 Million
Q1 2023 Apr 03, 2023	SELL	$310.63 - $364.82 $19,259 - $22,618	-62 Reduced 0.42%	14,828 $5.09 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $409,976 - $477,704	1,275 Added 9.36%	14,890 $5.45 Million
Q3 2022 Oct 03, 2022	SELL	$296.48 - $337.87 $94,873 - $108,118	-320 Reduced 2.3%	13,615 $4.4 Million
Q2 2022 Jul 01, 2022	SELL	$278.73 - $327.27 $74,142 - $87,053	-266 Reduced 1.87%	13,935 $4.52 Million
Q1 2022 Apr 01, 2022	SELL	$234.69 - $291.66 $222,486 - $276,493	-948 Reduced 6.26%	14,201 $4.07 Million
Q4 2021 Jan 04, 2022	SELL	$224.85 - $279.04 $138,057 - $171,330	-614 Reduced 3.9%	15,149 $4.19 Million
Q3 2021 Oct 01, 2021	SELL	$221.6 - $272.71 $532,061 - $654,776	-2,401 Reduced 13.22%	15,763 $3.64 Million
Q2 2021 Jul 01, 2021	SELL	$180.55 - $233.54 $541,469 - $700,386	-2,999 Reduced 14.17%	18,164 $4.17 Million
Q1 2021 Apr 01, 2021	SELL	$164.32 - $212.72 $693,101 - $897,252	-4,218 Reduced 16.62%	21,163 $3.95 Million
Q4 2020 Jan 04, 2021	SELL	$130.46 - $172.63 $90,800 - $120,150	-696 Reduced 2.67%	25,381 $4.29 Million
Q3 2020 Oct 01, 2020	SELL	$146.22 - $169.13 $1.26 Million - $1.46 Million	-8,603 Reduced 24.81%	26,077 $3.86 Million
Q2 2020 Jul 01, 2020	SELL	$136.42 - $164.18 $670,095 - $806,452	-4,912 Reduced 12.41%	34,680 $5.69 Million
Q1 2020 Apr 01, 2020	SELL	$119.05 - $147.35 $512,867 - $634,783	-4,308 Reduced 9.81%	39,592 $5.49 Million
Q4 2019 Jan 02, 2020	SELL	$106.92 - $132.43 $301,193 - $373,055	-2,817 Reduced 6.03%	43,900 $5.77 Million
Q3 2019 Oct 01, 2019	SELL	$106.79 - $116.16 $101,770 - $110,700	-953 Reduced 2.0%	46,717 $5.23 Million
Q2 2019 Jul 01, 2019	SELL	$110.79 - $129.32 $933,738 - $1.09 Million	-8,428 Reduced 15.02%	47,670 $5.28 Million
Q1 2019 Apr 01, 2019	SELL	$111.31 - $131.02 $617,993 - $727,423	-5,552 Reduced 9.01%	56,098 $7.28 Million
Q4 2018 Jan 02, 2019	SELL	$105.9 - $118.64 $2.55 Million - $2.86 Million	-24,080 Reduced 28.09%	61,650 $7.14 Million
Q3 2018 Oct 02, 2018	SELL	$85.86 - $107.31 $1.49 Million - $1.87 Million	-17,385 Reduced 16.86%	85,730 $9.2 Million
Q2 2018 Jul 02, 2018	BUY	$75.7 - $86.88 $1.34 Million - $1.54 Million	17,766 Added 20.82%	103,115 $8.8 Million
Q1 2018 Apr 02, 2018	BUY	$74.21 - $87.6 $2.04 Million - $2.41 Million	27,556 Added 47.68%	85,349 $6.6 Million
Q4 2017 Jan 02, 2018	SELL	$81.94 - $87.89 $799,160 - $857,191	-9,753 Reduced 14.44%	57,793 $4.88 Million
Q3 2017 Oct 02, 2017	BUY	$77.07 - $85.54 $5.21 Million - $5.78 Million	67,546	67,546 $5.78 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Eli Lilly & CO Transaction History